Search the Community
Showing results for tags 'strategy'.
WASHINGTON, DC (March 14, 2018) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, today announced the addition of the President of Vogue International, a Johnson & Johnson Company, Michael Marquis to its Board of Directors. Working together with other global leaders on the Board, Marquis will lend his knowledge and passion to further LUNGevity’s work of changing outcomes for people with lung cancer. “We are excited and honored that Michael is joining our board,” said Andrea Ferris, CEO of LUNGevity Foundation. “His long track record as an innovative leader at J&J, and his insight into how people view their health options, will be a tremendous benefit to the Foundation’s ability to reach key audiences.” “After losing my mother to lung cancer in 2014, I became painfully aware of the work that was needed in the lung cancer space. I was excited to work with LUNGevity over the past few years to hone their marketing messaging,” said Marquis. “I have a deep appreciation for the work that LUNGevity does and I am honored to have this opportunity to help lay the strategic groundwork for the years of progress that are ahead of us.” Michael was appointed President of Vogue in 2016 and tasked with completing a seamless merger into J&J while plotting a path for Vogue’s growth. As a valued member of the North American Leadership Team at J&J, he works in partnership with the other consumer brands to contribute to the advancement of human health in conjunction with the Credo of Johnson & Johnson. In 2014, Michael took on the leadership of the portfolio of businesses including iconic brands LISTERINE® and BAND-AID®. By focusing on core priorities and establishing a culture of health and learning, he was able to grow market shares of key product lines and build a team of leaders for the future. Prior to that, Michael was responsible for the Global Oral Care Franchise at J&J, where he headed up global strategy, marketing, innovation and business development into emerging markets. Mr. Marquis graduated from Bucknell University with a bachelor’s degree in accounting. Read the full press release.
WASHINGTON, DC (March 14, 2018) — LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, today announced that Andre Owens, partner in the Washington, D.C., law office of WilmerHale, has joined the Board of Directors. Together with other global leaders on the Board, Owens will lend his expertise to further LUNGevity’s work of changing outcomes for people with lung cancer. “We are grateful to have someone as uniquely qualified as Andre join our Board,” said Andrea Ferris, CEO of LUNGevity Foundation. “His valuable specialized knowledge coupled with a strong personal motivation for increasing survivorship in lung cancer makes Andre a great addition to help steer the Foundation’s research, education, support, and public policy programs.” “Like so many others, I have been personally affected by the loss of loved ones to lung cancer,” explains Owens. “While there has been some progress in the lung cancer space, we still have a lot more to do. I am proud and honored to help LUNGevity achieve its vision of creating a world where no one dies of lung cancer.” Andre’s legal practice focuses on securities trading and markets activities. He counsels broker-dealers, securities exchanges, investment advisers, and other clients on a variety of regulatory issues. In the past, Andre served as a member of the U.S. Securities and Exchange Commission’s Office of General Counsel. He also served as counsel to former SEC Commissioner Steven M. H. Wallman. Mr. Owens graduated from Providence College with a bachelor’s degree and holds a JD degree from Harvard Law School. Read the full press release.